AP2 inhibits cancer cell growth and activates p21(WAF1/CIP1) expression

Nature Genetics

Volumn 15, Issue 1, 1997, Pages 78-82

  Zeng, Yi Xin ^a   Somasundaram, Kumaravel ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL ESTER; PROTEIN P21; TRANSCRIPTION FACTOR AP 2;

ARTICLE; BINDING SITE; CANCER INHIBITION; CELL DIFFERENTIATION; DNA BINDING; DNA SEQUENCE; DNA SYNTHESIS INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 6; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031012251     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0197-78     Document Type: Article

References (32)

1. Mitchell, P.J., Wang, C. & Tjian, R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50, 847-861 (1987).
2. Williams, T., Admon, A., Luscher, B. & Tjian, R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2, 1557-1569 (1988).
3. Imagawa, M., Chiu, R. & Karin, M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51, 251-260 (1987).
4. Luscher, B., Mitchell, P.J., Williams, T. & Tjian, R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 3, 1507-1157 (1989).
5. Schorle, H., Meier, P., Buchert, M., Jaenisch, R. & Mitchell, P.J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235-238 (1996).
6. Zhang, J. et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature, 381, 238-241 (1996).
7. Michieli, P. et al. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395 (1994).
8. Steinman, R.A. et al. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9, 389-396 (1994).
9. Macleod, K.F. et al. p53-dependent and independent expression of p21 during cell growth, differentiation & DNA damage. Genes Dev. 9, 935-944 (1995).
10. Halevy, O. et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021 (1995).
11. Liu, M., Lee, M.H., Cohen, M., Bommakanti, M. & Freedman, L.P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153 (1996).
12. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910-2919 (1995).
13. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12, 1557-1564 (1996).
14. Kharbanda, S. et al. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 269, 872-878 (1994).
15. Sato, E.F., Edashige, K., Inoue, M. & Utsumi, K. Okadaic acid increased annexin I and induced differentiation of promyelocytic leukemia cells. Biochim. Biophys. Acta. 1266, 23-30 (1995).
16. Williams, T. & Tjian, R. Analysis of the DNA-binding and activation properties of the transcription factor AP-2. Genes Dev. 5, 670-682 (1991).
17. Kannan, P. et al. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8, 1258-1269 (1994).
18. Gaynor, R.B. et al. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 10, 1100-1102 (1991).
19. Trent, J.M. et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247, 568-71 (1990).
20. Foulkes, W.D., Ragoussis, J., Stamp, G.W., Allan, G.J. & Trowsdale, J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer 67, 551-9 (1993).
21. Nawroz, H. et al. Allelotype of head and neck aquamous cell carcinoma. Cancer Res. 54, 1152-1155 (1994).
22. Robertson, G.P., Coleman, A.B. & Lugo, T.G. Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res. 56, 1635-1641 (1996).
23. Somasundaram, K. et al. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc. Natl. Acad. Sci. USA 93, 3088-3093 (1996).
24. Buettner, R. et al. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol. 13, 4174-4185 (1993).
25. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
26. Hyman, S.E., Comb, M., Pearlberg, J. & Goodman, H.M. An AP-2 element acts synergistically with the cyclic AMP-and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol. Cell. Biol. 9, 321-324 (1989).
27. Duan, C. & Clemmons, D.R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem. 270, 24844-24851 (1995).
28. Bosher, J.M., Williams, T. & Hurst H.C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl. Acad. Sci. USA 92, 744-747 (1995).
29. Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT/enhancer-binding protein a (C/EBPα) inhibits cell proliferation through the p21 (WAF1/CIP1/SDI-1) protein. Genes Dev. 10, 804-815 (1996).
30. WAF1/CIP1 mediated by STAT1. Science 272, 719-722 (1996).
31. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
32. Kastan, M.B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).